Physician profile
Danny Mou
NPI 1922493121
$8,007.28
in general payments reported to CMS, 2019-2025
6 companies · $1,696 in 2025
The $1,696 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,218 · 2023: $724 · 2024: $4,369 · 2025: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $1,028 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250 · Travel and Lodging: $11.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $1,028.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
| Travel and Lodging | $11.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,210.31 | 2022-2025 | Da Vinci Sp, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $526.62 | 2022-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Medtronic, INC. | $176.37 | 2025 | Signia, Ligasure |
| Novo Nordisk INC | $37.24 | 2024 | |
| Boston Scientific Corporation | $35.74 | 2024 | Spyglass Discover |
| Virtual Incision Corporation | $21.00 | 2024 | Mira |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Mou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.